Updated May 1, 2018

The uninsured rate is rising again

Expand chart
Reproduced from The Commonwealth Fund Affordable Care Act Tracking Surveys; Note: Surveys conducted July–Sept. 2013, April–June 2014, March–May 2015, Feb.–April 2016, March–June 2017, Feb.–March 2018. Chart: Axios Visuals

The number of Americans without health insurance is creeping back up, after seeing a big drop once the Affordable Care Act took effect, according to the latest tracking survey from the Commonwealth Fund.

The numbers that matter: About 15.5% of adults are uninsured, by Commonwealth’s count, up roughly three percentage points from the same time in 2016. That represents an increase of about 4 million people, the organization said.

Between the lines: Lower-income families saw the biggest coverage losses. Families making more than about $60,000 per year saw relatively stable coverage levels.

The context: Commonwealth attributes the increase largely to the way Congress and the Trump administration has handled the ACA.

  • The survey accounts for all sources of coverage, not just the individual market or the ACA’s exchanges, but lower-income households are more likely to rely on the exchanges or the ACA’s Medicaid expansion.

Yes, but: Roughly 11.8 million people selected insurance plans through the ACA’s exchanges in the most recent open enrollment period — nearly identical to the number who bought coverage for 2016.

Go deeper

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.